Absolute immature platelet count helps differentiate thrombotic thrombocytopenic purpura from hypertension-induced thrombotic microangiopathy

Transfusion and Apheresis Science

Volumn 51, Issue 1, 2014, Pages 54-57

  Zheng, Yan ^a,b   Hong, Hong ^a,b   Reeves, Hollie M ^a,b   Maitta, Robert W ^a,b  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

IPF; Absolute immature platelet count; Hypertension; Therapeutic plasma exchange; Thrombotic microangiopathy; Thrombotic thrombocytopenic purpura

Indexed keywords

AMLODIPINE; D DIMER; HAPTOGLOBIN; HEMOGLOBIN; HYDRALAZINE; LABETALOL; LACTATE DEHYDROGENASE; NICARDIPINE; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ABSOLUTE IMMATURE PLATELET COUNT; ACUTE KIDNEY FAILURE; ADULT; ANTIHYPERTENSIVE THERAPY; APHERESIS DEVICE; ARTICLE; BLOOD PRESSURE REGULATION; CASE REPORT; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; FEMALE; HUMAN; HYPERTENSION; HYPERTENSION INDUCED THROMBOTIC MICROANGIOPATHY; LABORATORY DIAGNOSIS; PLASMAPHERESIS; THROMBOCYTE COUNT; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT WITHDRAWAL; BLOOD; PURPURA, THROMBOTIC THROMBOCYTOPENIC; THROMBOCYTOPOIESIS; THROMBOTIC MICROANGIOPATHIES;

ADULT; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; HYPERTENSION; PLATELET COUNT; PURPURA, THROMBOTIC THROMBOCYTOPENIC; THROMBOPOIESIS; THROMBOTIC MICROANGIOPATHIES;

EID: 84930044012     PISSN: 14730502     EISSN: 18781683     Source Type: Journal    
DOI: 10.1016/j.transci.2014.07.004     Document Type: Article

References (22)

1. Tsai H.M. Untying the knot of thrombotic thrombocytopenic purpura and atypical hemolytic uremic syndrome. Am J Med 2013, 126(3):200-209.
2. Rock G.A., Shumak K.H., Buskard N.A., Blanchette V.S., Kelton J.G., Nair R.C., et al. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. NEJM 1991, 325(6):393-397.
3. Amorosi E.L., Karpatkin S. Antiplatelet treatment of thrombotic thrombocytopenic purpura. Ann Intern Med 1977, 86(1):102-106.
4. Tsai H.M. Pathophysiology of thrombotic thrombocytopenic purpura. Int J Hematol 2010, 91(1):1-19.
5. Sadler J.E. Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura. Blood 2008, 112(1):11-18.
6. Maitta R.W., Zhou L. Immature platelet fraction: coming of age of an underutilized test in the setting of thrombotic thrombocytopenic purpura. J Blood Disord Transf 2014, 5(5):1000e1114.
7. Briggs C., Kunka S., Hart D., Oguni S., Machin S.J. Assessment of an immature platelet fraction (IPF) in peripheral thrombocytopenia. Br J Haematol 2004, 126(1):93-99.
8. Barsam S.J., Psaila B., Forestier M., Page L.K., Sloane P.A., Geyer J.T., et al. Platelet production and platelet destruction: assessing mechanisms of treatment effect in immune thrombocytopenia. Blood 2011, 117(21):5723-5732.
9. Zucker M.L., Murphy C.A., Rachel J.M., Martinez G.A., Abhyankar S., McGuirk J.P., et al. Immature platelet fraction as a predictor of platelet recovery following hematopoietic progenitor cell transplantation. Lab Hematol 2006, 12(3):125-130.
10. Kier Y.E., Stempak L.M., Maitta R.W. Immature platelet fraction can help adjust therapy in refractory thrombotic microangiopathic hemolytic anemia cases. Transfus Apher Sci 2013, 49(3):644-646.
11. Hong H., Stempak L.M., Sandhaus L.M., Maitta R.W. Absolute immature platelet count increment predicts the clinical course of thrombotic thrombocytopenic purpura (TTP) patients. Transfusion 2013, 53(2S). S22-020A.
12. Hong H., Xiao W., Maitta R.W. Steady increment of immature platelet fraction is suppressed by irradiation in single-donor platelet components during storage. PLoS ONE 2014, 9(1):e85465.
13. Zampaglione B., Pascale C., Marchisio M., Cavallo-Perin P. Hypertensive urgencies and emergencies. Prevalence and clinical presentation. Hypertension 1996, 27(1):144-147.
14. Akimoto T., Muto S., Ito C., Takahashi H., Takeda S., Ando Y., et al. Clinical features of malignant hypertension with thrombotic microangiopathy. Clin Exp Hypertens 2011, 33(2):77-83.
15. Khanna A., McCullough P.A. Malignant hypertension presenting as hemolysis, thrombocytopenia, and renal failure. Rev Cardiovasc Med 2003, 4(4):255-259.
16. Rifkin B.S., Brewster U.C. Thrombotic microangiopathy associated with malignant hypertension. Mayo Clin Proc 2006, 81(5):593.
17. Shibagaki Y., Fujita T. Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)/thrombotic thrombocytopenic purpura (TTP): can we differentiate one from the other?. Hypertens Res 2005, 28(1):89-95.
18. Shavit L., Reinus C., Slotki I. Severe renal failure and microangiopathic hemolysis induced by malignant hypertension - case series and review of literature. Clin Nephrol 2010, 73(2):147-152.
19. Vaughan C.J., Delanty N. Hypertensive emergencies. Lancet 2000, 356(9227):411-417.
20. van den Born B.J., van der Hoeven N.V., Groot E., Lenting P.J., Meijers J.C., Levi M., et al. Association between thrombotic microangiopathy and reduced ADAMTS13 activity in malignant hypertension. Hypertension 2008, 51(4):862-866.
21. Deford C.C., Reese J.A., Schwartz L.H., Perdue J.J., Kremer Hovinga J.A., Lammle B., et al. Multiple major morbidities and increased mortality during long-term follow-up after recovery from thrombotic thrombocytopenic purpura. Blood 2013, 122(12):2023-2029.
22. Schwartz J., Winters J.L., Padmanabhan A., Balogun R.A., Delaney M., Linenberger M.L., et al. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the sixth special issue. J Clin Apher 2013, 28(3):145-284.